BioSpace News Archive

VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that Jeff Baxter, VBI’s President and CEO, will participate in an analyst-led fireside chat at the Jefferies Healthcare Conference on Wednesday, June 8, 2022.

Biocept, Inc. (Nasdaq: BIOC) management will hold a conference call today, June 7, 2022, beginning at 4:00 p.m. Eastern time to discuss its re-focused and rationalized business strategy and to answer questions.

Twist MRD Rapid 500 Panel Enables Customers to Implement Fully Customizable Panels for $50 per Sample.

IQVIA (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and contract services to the life sciences industry, today announced the appointment of Dr. Christina Mack to serve as chief scientific officer for the company’s Real World Solutions (RWS) business, effective July 7, 2022.

Pieces, a healthcare AI company, has been chosen as the technology partner for NRG Oncology’s FORTE study to accelerate the identification of participants eligible for a major clinical trial.

Ichnos Sciences Inc., a clinical-stage global biotechnology company developing innovative multispecific antibodies for oncology, today announced that its president and chief executive officer, Cyril Konto, M.D., will present at the 2022 Jefferies Healthcare Conference in New York on Friday, June 10 at 10:00 AM Eastern Time.

Daiichi Sankyo (TSE: 4568) and Sarah Cannon Research Institute (Sarah Cannon) announced that initial results from the first-in-human phase 1 study of DS-6000, a CDH6 directed DXd antibody drug conjugate (ADC), suggest early clinical activity in patients with advanced ovarian cancer or renal cell carcinoma with disease progression following standard of care treatment.

Demonstrates increasing company commitment to responsible value creation.

Pioneering scientists at VIB, the University of Copenhagen, DKFZ, and Stanford University are the first to deploy systems that deliver highest-resolution view of subcellular gene expression activity.

NuGen Medical Devices Inc. is pleased to announce the launch of a new online brand store for its InsuJet TM needle-free injection device.